The time a patient is in a doctor's office represents a very small window of the body normally, which makes out-of-office blood pressure measurements important to confirm diagnosis of hypertension, explained Paul Whelton, MD, MSc, professor of global public health at Tulane University.
The time a patient is in a doctor's office represents a very small window of the body normally, which makes out-of-office blood pressure measurements important to confirm diagnosis of hypertension, explained Paul Whelton, MD, MSc, professor of global public health at Tulane University.
Transcript
The new hypertension guideline emphasizes the need for measuring blood pressure when patients are not in the physician's office. Why is this important?
The measurement is very important. Obviously, we're going to make key decisions to label somebody as having high blood pressure and to maybe instigate therapy—lifestyle or drugs. And so we emphasize accurate measurements of blood pressure. we emphasize getting the average estimate of blood pressure, and we emphasize out-of-office blood pressure measurements, because we realize that once you get in the office, there's a very narrow window of what the body sees. So, it's important to get out-of-office measures to confirm the diagnosis of hypertension in the office, and to recognize white coat hypertension, or to recognize, more importantly, masked hypertension.
So for all of those reasons, we've put a strong emphasis on out-of-office blood pressure measurements. And, of course, in the United States, that's mostly going to be home blood pressure measurements, so the patient needs to be instructed how to get accurate measuremnts.
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More